Effects of the concomitant administration of tamsulosin (0.8 mg) on the pharmacokinetic and safety profile of intravenous digoxin (LANOXIN) in normal healthy subjects: a placebo-controlled evaluation.
A 20-day, nonrandomized, open-label, placebo-controlled study was performed to investigate whether concomitant administration of tamsulosin (0.8 mg) affects the pharmacokinetic and safety profile of intravenous digoxin (0.5 mg) in healthy subjects. Ten healthy subjects aged 21-39 years received a si...
| Publicado en: | Journal of Clinical Pharmacy & Therapeutics Vol. 27; no. 1; pp. 13 - 20 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
Feb2002
|
| Acceso en línea: | Ver este registro en EBSCOhost |